Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib for Hospitalized Adults With COVID-19
NCT04579393Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Oct 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fostamatinib in coronavirus disease 2019 (COVID-19), sponsored by National Heart, Lung, and Blood Institute. Started Oct 2020; status: completed.
02
Drugs
fostamatinib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04579393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04579393.